A 3 year study to determine if optical coherence tomography can be used to measure disease progression in patients with multiple sclerosis

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-001437-16

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate change in RNFL thickness in RRMS patients followed for up to 36 months compared to a group of reference subjects (without neurologic or ophthalmic disease) to determine whether the optical coherence tomography (OCT) technology is sufficiently sensitive to disease and to change over time.


Critère d'inclusion

  • Multiple sclerosis

Liens